CD8A and cancer: In subtype C, a larger number of infiltrated effector CD8 + T cells (CD8+/GZMK+) and spatial co-option with PD-L1+ cancer cells (Fig. 5h) were observed compared to the other three subtypes (Supplementary Fig. 8).